Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Injection vs Victoza in Type 2 Diabetes Mellitus
CTR20210173Phase 3Completed
- Sponsor
- Chongqing Paijin Biotechnology
- Start
- Jan 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Chongqing Paijin Biotechnology. Started Jan 2021; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20210173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210173.